Patents by Inventor Qishan Wang

Qishan Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SNP MARKER COMBINATION AND IDENTIFICATION METHOD FOR PUDONG WHITE PIGS AND RAW MEAT PRODUCTS
    Publication number: 20220228225
    Abstract: The present invention discloses a SNP marker combination and an identification method for Pudong white pigs and raw meat products thereof, including: extracting genomic DNAs of raw pork or meat products, performing agarose gel electrophoresis and Sanger sequencing after PCR amplification, and identifying Pudong white pigs and meat products thereof according to SNP genotypes of characteristic loci of sequencing results; as for the Sanger sequencing, its identification loci are as follows: specific mutations occur at loci of pig18-52722267, pig8-146130825, pig9-10041850 and pig13-213464983. The present invention solves the problem that there is no identification method related to Pudong white pigs and meat products thereof in the prior art.
    Type: Application
    Filed: December 31, 2019
    Publication date: July 21, 2022
    Inventors: Yuchun PAN, Qishan WANG, Zhe ZHANG, Zhen WANG
  • 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors
    Patent number: 8648086
    Abstract: The present invention provides 5,6-bicyclic heteroaryl-containing urea compounds of Formula I or II and use of the same for treating conditions mediated by protein kinase such as VEGFR2, c-Met, PDGFR? c-Kit, CSF1R, or EphA2.
    Type: Grant
    Filed: August 20, 2010
    Date of Patent: February 11, 2014
    Assignee: Ascepion Pharmaceuticals, Inc.
    Inventors: Shan Jiang, Xinglong Xing, Qishan Wang, Ren Kong
  • DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS
    Publication number: 20130165475
    Abstract: The present invention provides deuterium-enriched heteroaryl-containing urea compounds (I) and use of the same for treating conditions mediated by protein kinase such as
    Type: Application
    Filed: September 1, 2011
    Publication date: June 27, 2013
    Applicant: ASCEPION PHARMACEUTICALS, INC.
    Inventors: Shan Jiang, Qishan Wang, Xiaoyong Gao
  • 5,6-BICYCLIC HETEROARYL-CONTAINING UREA COMPOUNDS AS KINASE INHIBITORS
    Publication number: 20120122895
    Abstract: The present invention provides 5,6-bicyclic heteroaryl-containing urea compounds of Formula I or II and use of the same for treating conditions mediated by protein kinase such as VEGFR2, c-Met, PDGFR? c-Kit, CSF1R, or EphA2.
    Type: Application
    Filed: August 20, 2010
    Publication date: May 17, 2012
    Inventors: Shan Jiang, Xinglong Xing, Qishan Wang, Ren Kong